期刊
ADVANCED HEALTHCARE MATERIALS
卷 7, 期 10, 页码 -出版社
WILEY
DOI: 10.1002/adhm.201701328
关键词
biomaterials; conjunctiva; cornea; regenerative medicine; tissue engineering
资金
- EPSRC [EP/M002209/1]
- MRC through the UKRMP-Acellular Technologies Hub [UKRMP003/14]
- EPSRC [EP/M002209/1] Funding Source: UKRI
- Engineering and Physical Sciences Research Council [EP/M002209/1] Funding Source: researchfish
The role of biomaterials in tissue engineering and regenerative medicine strategies to treat vision loss associated with damage to tissues in the anterior segment of the eye has been studied for several years. This has mostly involved replacement and support for the cornea and conjunctiva. These are complex tissues with specific functional requirements for different parts of the tissue. Amniotic membrane (AM) is used in clinical practice to transplant autologous or allogenic cells to the corneal surface. Fibrin gels have also progressed to clinical use under specific conditions. Alternatives to AM such as collagen gels, other natural materials, for example keratin and silks, and synthetic polymers have received considerable attention in laboratory and animal studies. This experience is building a body of evidence to demonstrate the potential of tissue engineering and regenerative medicine in corneal and conjunctival reconstruction and can also lead to other applications in the anterior segment of the eye, for example, the trabecular meshwork. There is a real clinical need for new procedures to overcome vision loss but there are also opportunities for developments in ocular applications to lead to biomaterials innovations for use in other clinical areas.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据